Financhill
Sell
31

MNPR Quote, Financials, Valuation and Earnings

Last price:
$32.67
Seasonality move :
-9.44%
Day range:
$26.06 - $33.38
52-week range:
$1.72 - $54.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.62x
Volume:
20K
Avg. volume:
32.8K
1-year change:
1004.64%
Market cap:
$199.4M
Revenue:
--
EPS (TTM):
-$1.99

Earnings Data

Next earnings date for MNPR
May 09
2025
Most recent earnings per share
-$2.75
Missed by $2.33
(Mar 31/2025)
Consensus Estimate
-$0.42
(Mar 31/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MNPR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 -- -- -- -$0.62 --
03/31/2025 Q1 -- -- -- -$0.57 --
03/31/2025 Q4 -- -- -$2.75 -$0.42 -$2.33
11/08/2024 Q3 -- -- -$0.37 -$1.17 $0.80
08/09/2024 Q2 -- -- -$0.50 -$0.47 -$0.03
05/09/2024 Q1 -- -- -$0.50 -$0.85 $0.35
03/28/2024 Q4 -- -- -$0.62 -$0.85 $0.23
11/09/2023 Q3 -- -- -$0.69 -$0.95 $0.26
08/11/2023 Q2 -- -- -$0.80 -$0.95 $0.15
05/11/2023 Q1 -- -- -$0.95 -$1.08 $0.13
03/23/2023 Q4 -- -- -$1.15 -$1.03 -$0.13
11/10/2022 Q3 -- -- -$0.95 -$1.08 $0.13
08/11/2022 Q2 -- -- -$1.10 -- --
05/12/2022 Q1 -- -- -$0.95 -- --
03/24/2022 Q4 -- -- -$1.05 -- --
11/12/2021 Q3 -- -- -$1.00 -- --
08/12/2021 Q2 -- -- -$0.85 -- --
05/13/2021 Q1 -- -- -$0.80 -- --
03/25/2021 Q4 -- -- -$0.95 -- --
11/12/2020 Q3 -- -- -$0.75 -- --
08/06/2020 Q2 -- -- -$0.70 -- --
05/07/2020 Q1 -- -- -$0.50 -- --
03/27/2020 Q4 -- -- -$0.57 -- --
09/30/2019 Q3 -- -- -$0.35 -- --
06/30/2019 Q2 -- -- -$0.43 -- --
03/31/2019 Q1 -- -- -$0.66 -- --
12/31/2018 Q4 -- -- -$0.43 -- --
09/30/2018 Q3 -- -- -$0.31 -- --
06/30/2018 Q2 -- -- -$0.36 -- --
03/31/2018 Q1 -- -- -$0.42 -- --
12/31/2017 Q4 -- -- -$0.34 -- --
09/30/2017 Q3 -- -- -$7.14 -- --
06/30/2017 Q2 -- -- -$0.28 -- --
03/31/2017 Q1 -- -- -$0.18 -- --

Monopar Therapeutics Earnings Questions

  • How Much did Monopar Therapeutics Generate in Revenue Last Quarter?

    Monopar Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Monopar Therapeutics Beat Earnings Last Quarter?

    Monopar Therapeutics announced earnings per share of -$2.75 which represents a miss of analyst forecast a -$0.42 per share.

  • Is Monopar Therapeutics Profitable?

    Monopar Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Monopar Therapeutics EPS Next Year?

    Monopar Therapeutics's earnings are forecast to decrease from -$4.11 per share to -$1.77 per share next year representing a decrease of -35.93%.

  • When is Monopar Therapeutics's Earnings Date?

    Monopar Therapeutics's next earnings date is May 9, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Realty Income the Best Dividend Stock to Buy Long-Term?
Is Realty Income the Best Dividend Stock to Buy Long-Term?

Realty Income (NYSE:O) is a longstanding real estate investment trust…

Is Archer Aviation a Buy, Sell or Hold?
Is Archer Aviation a Buy, Sell or Hold?

Vertical takeoff and landing (eVTOL) aircraft sound futuristic but that’s…

Down 50%, Is Dell Technologies a Buy?
Down 50%, Is Dell Technologies a Buy?

Dell (NYSE:DELL)’s share price has been on a roller coaster…

Stock Ideas

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Sell
33
BULZ alert for Apr 10

MicroSectors Solactive FANG & Innov 3X Levd ETN [BULZ] is down 15.35% over the past day.

Sell
31
TECS alert for Apr 10

Direxion Daily Technology Bear 3x Shares [TECS] is up 12.66% over the past day.

Sell
48
FNGA alert for Apr 10

MicroSectors FANG+ Index 3X Leveraged ETN [FNGA] is down 13.3% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock